VirTra Shines with Record-Breaking Revenue, Beam Global Beats Expectations, Eloxx Pharmaceuticals Misses Estimates, Ducommun Launches Public Offering
- May 15th, 2023
- 574 views
VirTra, Inc. (Nasdaq: VTSI) achieved remarkable double-digit millions in quarterly revenue for the first time, surpassing expectations with Q1 2023 earnings per share (EPS) of $0.27 compared to the consensus estimate of $0.04.
In after-hours trading, $VTSI is currently valued at $6.99, experiencing a notable increase of $1.07 (+18.07%).
Beam Global (Nasdaq: BEEM) reported a loss of $0.38 per share for the first quarter 2023, performing better than the consensus estimate of a loss of $0.42 per share.
$BEEM is trading at $11.69 in after-hours, reflecting a significant gain of $1.66 (+16.55%).
Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) reported a loss of $2.88 per share for Q1 2023, worse than the consensus estimate of a loss of $2.55 per share.
In after-hours trading, $ELOX is currently valued at $8.23, experiencing a decline of $2.67 (-24.50%).
Ducommun Incorporated (NYSE: DCO) announced the launch of an underwritten public offering of 2,000,000 shares of its common stock.
Following this announcement, $DCO is trading at $43.75 in after-hours, indicating a decrease of $4.67 (-9.64%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026




Member Login